These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8794249)

  • 1. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Carter BJ; Flotte TR
    Curr Top Microbiol Immunol; 1996; 218():119-44. PubMed ID: 8794249
    [No Abstract]   [Full Text] [Related]  

  • 2. Adeno-associated virus vectors for gene therapy of cystic fibrosis.
    Flotte TR; Carter BJ
    Methods Enzymol; 1998; 292():717-32. PubMed ID: 9711594
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
    Guggino WB; Cebotaru L
    Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis gene therapy.
    Colledge WH
    Curr Opin Genet Dev; 1994 Jun; 4(3):466-71. PubMed ID: 7522673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease.
    Flotte T; Carter B; Conrad C; Guggino W; Reynolds T; Rosenstein B; Taylor G; Walden S; Wetzel R
    Hum Gene Ther; 1996 Jun; 7(9):1145-59. PubMed ID: 8773517
    [No Abstract]   [Full Text] [Related]  

  • 7. Breathing Easier: Molecular Therapeutics for Cystic Fibrosis.
    Limberis MP
    Hum Gene Ther; 2020 Sep; 31(17-18):905-906. PubMed ID: 32945723
    [No Abstract]   [Full Text] [Related]  

  • 8. Laying the Foundation for Cystic Fibrosis Therapy: An Interview with Michael Boyle.
    Davies K
    Hum Gene Ther; 2020 Sep; 31(17-18):917-920. PubMed ID: 32924627
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene Therapy for Respiratory Diseases: Progress and a Changing Context.
    Alton EWFW; Boyd AC; Davies JC; Gill DR; Griesenbach U; Harman TE; Hyde S; McLachlan G
    Hum Gene Ther; 2020 Sep; 31(17-18):911-916. PubMed ID: 32746737
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
    Flotte TR
    Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
    Guggino WB; Cebotaru L
    Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis.
    Wagner JA; Moran ML; Messner AH; Daifuku R; Conrad CK; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Hum Gene Ther; 1998 Apr; 9(6):889-909. PubMed ID: 9581911
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo gene therapy with adeno-associated virus vectors for cystic fibrosis.
    Flotte TR; Carter BJ
    Adv Pharmacol; 1997; 40():85-101. PubMed ID: 9217924
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
    Flotte TR; Afione SA; Conrad C; McGrath SA; Solow R; Oka H; Zeitlin PL; Guggino WB; Carter BJ
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10613-7. PubMed ID: 7504271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus for cystic fibrosis gene therapy.
    Martini SV; Rocco PR; Morales MM
    Braz J Med Biol Res; 2011 Nov; 44(11):1097-104. PubMed ID: 21952739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates.
    Fischer AC; Smith CI; Cebotaru L; Zhang X; Askin FB; Wright J; Guggino SE; Adams RJ; Flotte T; Guggino WB
    Mol Ther; 2007 Apr; 15(4):756-63. PubMed ID: 17299412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.